1. Home
  2. |Insights
  3. |Deal Note: Crowell & Moring Client Integrated BioTherapeutics Enters Into Exclusive Agreement with Chembio Diagnostics to Develop POC Diagnostic Tests for Ebola

Deal Note: Crowell & Moring Client Integrated BioTherapeutics Enters Into Exclusive Agreement with Chembio Diagnostics to Develop POC Diagnostic Tests for Ebola

Firm News | less than 1 min read | 10.27.14

Washington, D.C. – October 27, 2014: Crowell & Moring, LLP is representing Integrated BioTherapeutics, Inc. (IBT), a biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases, as it enters into an exclusive agreement with Chembio Diagnostics, Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases. Under the terms of the agreement, Chembio will combine its patented DPP technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness. Chembio will have exclusive rights to any POC product developed through this agreement. Financial terms of the agreement were not disclosed.

Insights

Firm News | 1 min read | 01.27.25

Crowell Represents Iron Health in Acquisition by Metronomic

San Fransisco – Jan. 27, 2024: A Crowell team successfully advised Iron Health in its acquisition by digital health startup Metronomic. Iron Health was founded over two years ago with an important mission: partner with OB/GYNs to address gaps in women’s health care through innovation. Since its founding, Iron Health built a novel model of care that provides accessible, equitable, quality women’s health care through a virtual care technology platform and multidisciplinary care team— all knitted into the trusted relationship women have with their OB/GYN. Through a strong track record of commercial partnerships across six states, Iron Health was able to provide access to more than 1 million women in the form of 4,000 patient visits, including behavioral health, weight management, nutrition, gestational diabetes, primary care, and menopause services....

View All Insights